Holen Sie sich die Stockscreener-App
44.54
0.85%
-0.38
Handel nachbörslich:
44.54
Schlusskurs vom Vortag:
$44.92
Offen:
$44.5
24-Stunden-Volumen:
401.11K
Relative Volume:
1.05
Marktkapitalisierung:
$3.18B
Einnahmen:
$751.00K
Nettoeinkommen (Verlust:
$-74.57M
KGV:
-40.38
EPS:
-1.1031
Netto-Cashflow:
$-55.52M
1W Leistung:
+5.02%
1M Leistung:
+74.94%
6M Leistung:
+93.57%
1J Leistung:
+157.31%
1-Tages-Spanne:
$43.75
$45.50
1-Wochen-Bereich:
$40.68
$46.97
52-Wochen-Spanne:
$12.56
$46.97
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
44.54 | 3.09B | 751.00K | -74.57M | -55.52M | -1.1031 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-07 | Eingeleitet | Oppenheimer | Outperform |
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Pulse Biosciences (PLSE) Is Up 5.0% After Wider Losses And $75M ATM Plan Filed – Has The Bull Case Changed? - simplywall.st
Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns - Yahoo Finance
Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform - marketbeat.com
(PLSE) Risk Channels and Responsive Allocation - Stock Traders Daily
Pulse Biosciences (PLSE) Prices A $75 Million Offering, Is The Stock Fully Valued? - Yahoo Finance
PLSE Virtual Meeting on Strategic Initiatives Highlights Growth Expectations Despite High Valuation - GuruFocus
Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year HighTime to Buy? - marketbeat.com
Pulse Biosciences stock reaches all-time high at 46.03 USD - Investing.com
Pulse Biosciences at Canaccord Genuity conference: nsPFA push gains pace By Investing.com - Investing.com Canada
PLSE: nsPFA technology delivers breakthrough efficacy in AFib and is poised for broad clinical adoption - TradingView
PLSE to Join BTIG Virtual Meeting Amid Elevated Price-to-Sales V - GuruFocus
PLSE Maintains Buy Rating by Canaccord Genuity -- Price Target R - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Pulse Biosciences (NASDAQ:PLSE) Stock Price - marketbeat.com
Canaccord raises Pulse Biosciences stock price target on clinical progress - Investing.com India
Canaccord raises Pulse Biosciences stock price target on clinical progress By Investing.com - Investing.com Canada
Weekly Recap: Q2 losses, ATM raises and NANOPULSE-AF study past halfway - TradingView
Pulse Biosciences (PLSE) After NANOPULSE AF Progress As Valuation Questions Build - Sahm
Pulse Biosciences (NASDAQ:PLSE) Announces Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
Pulse Biosciences, Inc. (PLSE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Pulse Biosciences (NASDAQ:PLSE) Stock Rating Lowered by Wall Street Zen - MarketBeat
Q2 2026 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Pulse Biosciences, Inc. (PLSE) stock price, news, quote and history - uk.finance.yahoo.com
Sector Update: Healthcare - moomoo.com
Pulse Biosciences Shares Rise After Q2 Results - marketscreener.com
Pulse Biosciences (NASDAQ:PLSE) Trading Up 15.7%Should You Buy? - MarketBeat
Pulse Biosciences enters $75 million equity distribution agreement with Mizuho - Investing.com Australia
Pulse Biosciences, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Pulse Biosciences (PLSE) Accelerates Clinical Enrollment, Market Pricing Reflects High Growth Expectations - GuruFocus
Form 8K Pulse Biosciences Inc For: 6 August By Investing.com - Investing.com Nigeria
Earnings call transcript: Pulse Biosciences misses Q2 2026 estimates but gains on trial progress - Investing.com Nigeria
Pulse Biosciences Inc (PLSE) (Q2 2026) Earnings Call Highlights: - GuruFocus
Did Pulse Biosciences (PLSE) Miss Revenue Estimates Despite Cash Influx? GF Score: 31/100 - GuruFocus
Pulse Biosciences Q2 Earnings Call Highlights - TradingView
Pulse Biosciences Q2 2026 Earnings Call Transcript - MarketBeat
Pulse Biosciences Inc (PLSE) (Q2 2026) Earnings Call Highlights: Accelerated Enrollment and ... - Yahoo Finance
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Pulse Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Pulse Biosciences earnings missed by $0.08, revenue fell short of estimates - Investing.com Canada
Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q2 Revenue $0.4M, vs. FactSet Est of $533K - marketscreener.com
PULSE BIOSCIENCES, INC. 2026: Revenue $434K, EPS ($0.36) — 10-Q Summary - TradingView
Pulse Biosciences posts Q2 2026 loss, $0.4M revenue and $101.6M cash - TradingView
Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results - Business Wire
Pulse Biosciences earnings on deck as PFA technology faces test By Investing.com - Investing.com Nigeria
Pulse Biosciences earnings on deck as PFA technology faces test - Investing.com
(PLSE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Pulse Biosciences Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Why Pulse Biosciences (PLSE) Is Up 6.4% After NANOPULSE-AF Trial Hits Enrollment Midpoint And What It Means - simplywall.st
Pulse Biosciences (NASDAQ:PLSE) Hits New 52-Week HighTime to Buy? - MarketBeat
Pulse Biosciences stock hits 52-week high at 36.79 USD - Investing.com
Pulse Biosciences stock hits 52-week high at 36.79 USD By Investing.com - Investing.com Canada
Pulse Biosciences (PLSE) Expected to Release Earnings on Thursday - marketbeat.com
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.90%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):